Back
SP Funds S&P 500 Sharia Industry Exclusions ETF Vs. NovoCure Industry Stock Comparison
Sell
47
SPUS
SP Funds S&P 500 Sharia Industry Exclusions ETF
Last Price:
$43.43
Seasonality Move:
5.15%
Sell
49
NVCR
NovoCure
Last Price:
$30.18
Seasonality Move:
-3.69%
Sell
47
SP Funds S&P 500 Sharia Industry Exclusions ETF (SPUS)
is a Sell
Is SP Funds S&P 500 Sharia Industry Exclusions ETF a Buy, Sell or Hold?
-
The current SP Funds S&P 500 Sharia Industry Exclusions ETF [SPUS] share price is $43.47. The Score for SPUS is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
SPUS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
NovoCure (NVCR)
is a Sell
Is NovoCure a Buy, Sell or Hold?
-
NVCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SPUS Stock Price Chart
What is SP Funds S&P 500 Sharia Industry Exclusions ETF's stock price today?
-
The SP Funds S&P 500 Sharia Industry Exclusions ETF share price today is $43.47The current trend is relatively stagnant and SPUS is experiencing buying pressure, which is a positive indicator for future bullish movement.
NVCR Stock Price Chart
SPUS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.09 | Buy |
| Relative Strength Index (14 RSI): | 50.59 | Buy |
| Chaikin Money Flow: | 138091 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (43.06 - 44.18) | Sell |
| Bollinger Bands (100): | (40.52 - 43.3) | Buy |
NVCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.94 | Buy |
| Relative Strength Index (14 RSI): | 58.79 | Buy |
| Chaikin Money Flow: | -60501 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.36 - 32.64) | Buy |
| Bollinger Bands (100): | (14.38 - 25.86) | Buy |
SPUS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 43.56 | Sell |
| 20-day SMA: | 43.76 | Sell |
| 50-day SMA: | 42.96 | Buy |
| 200-day SMA: | 40.34 | Buy |
| 8-day EMA: | 43.43 | Buy |
| 20-day EMA: | 43.49 | Sell |
| 50-day EMA: | 42.98 | Buy |
| 200-day EMA: | 40.3 | Buy |
NVCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 30.52 | Sell |
| 20-day SMA: | 30.41 | Sell |
| 50-day SMA: | 23.25 | Buy |
| 200-day SMA: | 18.89 | Buy |
| 8-day EMA: | 30.36 | Sell |
| 20-day EMA: | 29.22 | Buy |
| 50-day EMA: | 25.18 | Buy |
| 200-day EMA: | 21.21 | Buy |
SP Funds S&P 500 Sharia Industry Exclusions ETF Earnings Growth & SPUS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
NovoCure Earnings Growth & NVCR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.31 per share, and an increase next year of $0.06 per share.
SP Funds S&P 500 Sharia Industry Exclusions ETF Technical Analysis
| Dec 18 | Dec 19 | Dec 20 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 18 | 19 | 20 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovoCure Technical Analysis
| Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||